Sanara MedTech, Inc. SMTI 深 滬
等待開盤 06-25 09:30:00 美东时间
22.89
+1.140
+5.24%
華盛通- 最 高23.035
- 今 開22.00
- 成交量 6.59万股
- 最 低 21.77
- 昨 收 21.75
- 總市值 2.10亿
- 52周最高 35.95
- 市盈率 靜 --
- 換手率 0.72%
- 52周最低 16.0465
- 委 比 -80.00%
- 總股本 916.40万
- 歷史最高 53.85
- 量 比 0.73
- 振 幅 5.82%
- 歷史最低 16.0465
- 每 手 1
- 風險率 5.08%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sanara Medtech Ends Previously Announced Services Agreement With The Catalyst Group; Not Obliged To Pay Penalty Over Agreement Termination
https://www.sec.gov/ix?doc=/Archives/edgar/data/714256/000149315226027274/form8-k.htm
06-05 04:30
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Ernexa Therapeutics (NASDAQ:ERNA) stock moved upwards by 79.4% to $12....
05-13 01:06
Sanara MedTech shares are trading higher after the company reported better-than-expected Q1 financial results.
Sanara MedTech shares are trading higher after the company reported better-than...
05-12 21:28
Transcript: Sanara MedTech Q1 2026 Earnings Conference Call
Sanara MedTech (NASDAQ:SMTI) held its first-quarter earnings conference call on...
05-12 20:23
Sanara MedTech Sees Q2 Sales $28.500M-$29.500M vs $28.650M Est
Sanara MedTech (NASDAQ:SMTI) sees Q2 sales of $28.500 million-$29.500 million vs $28.650 million analyst estimate.
05-12 05:19
Sanara MedTech Q1 EPS $0.05 Beats $(0.04) Estimate, Sales $27.799M Beat $26.800M Estimate
Sanara MedTech (NASDAQ:SMTI) reported quarterly earnings of $0.05 per share which beat the analyst consensus estimate of $(0.04) by 225 percent. This is a 112.2 percent increase over losses of $(0.41) per share from the
05-12 05:12
美股大行评级 | 大行互评！花旗银行、贝莱德获多家大行上调目标价；哈里伯顿、强生、Patterson获多家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Knightscope"买入"评级，目标价从25美元升至26美元；杰富瑞：维持Allogene疗法"买入"评级，目标价从6美元升至10美元
04-16 10:14
Lake Street Initiates Coverage On Sanara MedTech with Buy Rating, Announces Price Target of $32
Lake Street analyst Frank Takkinen initiates coverage on Sanara MedTech (NASDAQ:SMTI) with a Buy rating and announces Price Target of $32.
04-15 22:18
Earnings Scheduled For March 24, 2026
Companies Reporting Before The Bell • Fennec Pharmaceuticals (NASDAQ:FENC) is e...
03-24 19:11
Sanara MedTech Affirms FY2026 Sales Guidance of $116.000M-$121.000M
Sanara MedTech (NASDAQ:SMTI) affirms FY2026 sales outlook from $116.000 million-$121.000 million to $116.000 million-$121.000 million.
03-24 19:06
